Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Centerview's Tokat Sees Potential for Mega Pharma Deals in 2026
A more permissive regulatory environment and Big Pharma's need to replenish revenue pipelines could spur the first $20 billion-plus M&A drug deal in more than three years, according to Centerview Partners Co-President Eric Tokat. “If there…
Trump administration urged to take on China's 'Pharma Death Grip
The push comes as policymakers recognize the United States relies heavily on China for key pharmaceutical materials, particularly the raw components of many antibiotics, while producing a small share domestically, China specialist Gordon Chang…
EU-approved sterile pharma facility launched
The launch of Sri Lanka's first locally manufactured self-dialysis solution bags by Kelun Lifesciences has coincided with the World Kidney Day. The company said the new supply bags, designed for home-based self-dialysis treatment, would benefit…
Zealand Pharma A/S (ZLDPF) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
Zealand Pharma A/S (ZLDPF) Barclays 28th Annual Global Healthcare Conference March 11, 2026 2:00 PM EDT Adam Steensberg - President & CEO Yihan Li - Barclays Bank PLC, Research Division Barclays Bank PLC, Research Division Hey, good afternoon…
Innocan Pharma Announces Offering of a Debenture to its Largest Shareholder, Tamar Innovest
HERZLIYA, Israel and CALGARY, AB, March 11, 2026 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the 'Company' or 'Innocan') is pleased to announce that it intends to complete an offering of a debenture of the Company (the…
China focus: a2 Milk Company, Otsuka Pharma, HMO approval and more
This round-up looks at news from a2 Milk Company and Otsuka Pharma, the third HMO approval in China, latest scientific findings and more.
Mayne Pharma Group Limited (MAYNF) Discusses U.S. Launch and Business Model of DistributeRx Transcript
Mayne Pharma Group Limited (MAYNF) Discusses U.S. Launch and Business Model of DistributeRx March 10, 2026 8:01 PM EDT Thomas Duthy - Manager of Investor Relations Aaron Gray - Chief Executive Officer Andrew Goodsall - MST Financial Services Pty…
Louis Lange Sells 28,186 Shares of NewAmsterdam Pharma (NASDAQ:NAMS) Stock
NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Get Free Report) Director Louis Lange sold 28,186 shares of the stock in a transaction on Friday, March 6th. The stock was sold at an average price of $29.41, for a total value of $828,950.26. The…
MNCs, Indian drugmakers diverge to mutual gain: How win-win is it?
The Novartis move is new in that it marks the first such total exit by an MNC in the Indian pharma market — partial divestments have been happening for years. The clearest signal came last month when Novartis decided to exit its listed arm.
Tracking Stanley Druckenmiller's Duquesne Family Office Portfolio - Q4 2025 Update
Duquesne Family Office's 13F portfolio value rose to ~$4.49B in Q4 2025, with 35 significant positions led by Natera, Insmed, Amazon.com, Teva Pharma, and Woodward. Major new stakes include Alcoa, Entegris, Lattice Semi, Bloom Energy, and Delta…
Harbor Health Care ETF Q4 2025 Commentary (MEDI)
During the fourth quarter, the Harbor Health Care ETF returned 10.43% (NAV), underperforming the Russell 3000 Growth Health Care Index, which returned 16.71%. The underperformance was primarily driven by stock selection and relative underexposure…
AptarGroup Isn't Ready For An Upgrade Just Yet (NYSE:ATR)
AptarGroup remains a soft 'Sell' as valuation is still high relative to peers despite solid operational performance. Revenue growth is robust across all segments, especially pharma and beauty, but margin pressures and mixed profitability persist.
Markets Crash Nearly 2%: BSE Sensex tumbled 1,342 pts; NSE Sinks Below 24K
Indian stock markets witnessed a sharp decline as the Sensex and Nifty tumbled due to surging crude oil prices, continuous foreign fund outflows, and selling pressure in key banking stocks, reflecting investor concerns over global economic…
Nifty Bank Prediction Today - March 11, 2026: Nifty Bank futures: Strong downward momentum
Nifty Bank index began today's session with a gap-down at 56,790 versus yesterday's close of 56,951. It fell after opening and is now hovering around 56,400, down 1 per cent so far today. Barring AU Small Finance Bank (up 0.4 per cent), the…
Sensex, Nifty tumble over 1%, down by 1,000+ points
Benchmark equity indices Sensex and Nifty were trading sharply lower during afternoon session on Wednesday after a day's breather as investors' sentiment remained cautious amid the ongoing tensions in West Asia and sustained foreign fund outflows.
Receive a Daily briefing on Pharma Industry News
Get Started